1-5 of 5
Karl Blume, MD
Close
Sort by
Journal Articles

Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative Host Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin Confirm a Low Incidence of Graft Versus Host Disease (GVHD) and Retained Graft Anti-Tumor Activity.

Robert Lowsky, MD, Keith Stockerl-Goldstein, MD, Ginna Laport, MD, David Miklos, MD, Sally Arai, MD, Judith Shizuru, MD, Laura Johnston, MD, Karl Blume, MD, Robert Negrin, MD, Samuel Strober, MD
Journal: Blood
Blood (2006) 108 (11): 603.
https://doi.org/10.1182/blood.V108.11.603.603
Published: 2006
Journal Articles

Relapse Risk after Nonmyeloablative Hematopoietic Cell Transplantation for Malignant Diseases.

Christoph Kahl, MD, Barry Storer, PhD, Marco Mielcarek, MD, Mike Maris, MD, Brenda Sandmaier, MD, David Maloney, MD, PhD, Thomas Chauncey, MD, Dietger Niederwieser, MD, Peter McSweeney, MD, Benedetto Bruno, MD, Karl Blume, MD, James Wade, MD, Jose Leis, MD, PhD, Emilia Langston, MD, Michael Pulsipher, MD, Edward Agura, MD, Rainer Storb, MD
Journal: Blood
Blood (2005) 106 (11): 703.
https://doi.org/10.1182/blood.V106.11.703.703
Published: 2005
Journal Articles

Prognostic Relevance of “Early-Onset” Graft-Versus-Host Disease Following Nonmyeloablative Hematopoietic Cell Transplantation.

Marco Mielcarek, MD, Lauri Burroughs, MD, Wendy Leisenring, PhD, Paul Martin, MD, Razvan Diaconezcu, MD, Brenda Sandmaier, MD, David Maloney, MD, PhD, Thomas Chauncey, MD, PhD, Michael Maris, MD, Judith Shizuru, MD, Karl Blume, MD, Ute Hegenbart, MD, Dietger Niederwieser, MD, Stephen Forman, MD, Benedetto Bruno, MD, Ann Woolfrey, MD, Rainer Storb, MD
Journal: Blood
Blood (2004) 104 (11): 423.
https://doi.org/10.1182/blood.V104.11.423.423
Published: 2004
Journal Articles

Non-Myeloablative Allografting from HLA-Identical Sibling Donors for Treatment of CML.

Fabio R. Kerbauy, MD, Thoralf Lange, MD, Ted Gooley, PhD, Judith Shizuru, MD, Jerald Radich, MD, David G. Maloney, MD, Edward Agura, MD, Benedetto Bruno, MD, Elliot Epner, MD, Thomas Chauncey, MD, PhD, Karl Blume, MD, Rainer Storb, MD, Dietger Niederwieser, MD, Brenda M. Sandmaier, MD
Journal: Blood
Blood (2004) 104 (11): 2316.
https://doi.org/10.1182/blood.V104.11.2316.2316
Published: 2004
Journal Articles

Nonmyeloablative Conditioning and Hematopoietic Cell Transplantation (HCT) from HLA-Matched Related or Unrelated Donors for Chemotherapy-Refractory Chronic Lymphocytic Leukemia (CLL).

Mohamed Sorror, MD, MSc, Michael Maris, MD, Barry Storer, PhD, Brenda Sandmaier, MD, Monic Stuart, MD, Ute Hegenbart, MD, Edward Agura, MD, Thomas Chauncey, MD, Jose Leis, MD, PhD, Michael Pulsipher, MD, Peter McSweeney, MD, Jerry Radich, MD, James Wade, MD, Benedetto Bruno, MD, Amelia Langston, MD, Dietger Niederwieser, MD, Karl Blume, MD, Rainer Storb, MD, David Maloney, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2323.
https://doi.org/10.1182/blood.V104.11.2323.2323
Published: 2004